Journal of Innovative Optical Health Sciences, Volume. 3, Issue 4, 279(2010)
COMBINED EFFECTS OF SELECTIVE PHOTOTHERMAL THERAPY AND IMMUNOADJUVANT AGAINST STAGE IV BREAST CANCER
[1] [1] World Health Organization: Programmes and projects: Media centre: Fact sheet N 297 (February 2009). Available: http://www.who.int/ mediacentre/factsheets/fs297/en/print.html [accessed July 27, 2010].
[2] [2] C. E. Holmes, H. B. Muss, “Diagnosis and treatment of breast cancer in the elderly,” CA Cancer J. Clin. 53, 227–244 (2003).
[3] [3] K. S. Anderson, “Tumor vaccines for breast cancer,” Cancer Invest. 27, 361–368 (2009).
[4] [4] W. R. Chen, R. L. Adams, R. Carubelli, R. E. Nordquist, “Laser-photosensitizer assisted immunotherapy: A novel modality in cancer treatment,” Cancer Lett. 115, 25–30 (1997).
[5] [5] W. R. Chen, H. Liu, J. W. Ritchey, K. E. Bartels, M. D. Lucroy, R. E. Nordquist, “Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats,” Cancer Res. 62, 4295– 4299 (2002).
[6] [6] W. R. Chen, W.-G. Zhu, J. R. Dynlacht, H. Liu, R. E. Nordquist, “Long-term tumor resistance induced by laser photo-immunotherapy,” Int. J. Cancer 81, 808–812 (1999).
[7] [7] M. F. Naylor, W. R. Chen, T. K. Teague, L. Perry, R. E. Nordquist, “In situ photo-immunotherapy: A tumor-directed treatment modality for melanoma,” Br. J. Dermatol. 155, 1287–1292 (2006).
[8] [8] X. Li, M. F. Naylor, R. E. Nordquist, T. T. Kent, H. C. Anthony, M. Cynthia, W. R. Chen, “Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: A preliminary study,” Cancer Biol. Ther. (2010), in press.
[9] [9] S. E. Singletary, J. L. Connolly, “Breast cancer staging: Working with the sixth edition of the AJCC Cancer Staging Manual,” CA Cancer J. Clin. 56, 37–47 (2006).
[10] [10] US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis: Common terminology criteria for adverse events v3.0 (CTCAE). Available: http://ctep.cancer.gov/ protocolDevelopment/electronic applications/docs/ ctcaev3.pdf [accessed September 28, 2009].
[11] [11] E. A. Eisenhauer, P. Therasse, J. Bogaerts, L. H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij, “New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1),” Eur. J. Cancer 45, 228–247 (2009).
[12] [12] MBC Advocacy Working Group, “Bridging gaps, expanding outreach: Metastatic Breast Cancer Advocacy Working Group Consensus Report,” Breast 18, 273–275 (2009).
[13] [13] W. R. Chen, A. K. Singhal, H. Liu, R. E. Nordquist, “Laser immunotherapy induced antitumor immunity and its adoptive transfer,” Cancer Res. 61, 459– 461 (2001).
[14] [14] W. R. Chen, H. Liu, J. A. Nordquist, R. E. Nordquist, “Tumor cell damage and leukocyte infiltration after laser immunotherapy treatment,” Lasers Med. Sci. 15, 43–48 (2000).
[15] [15] W. R. Chen, S. W. Jeong,M. D. Lucroy, R. F.Wolf, E. W. Howard, H. Liu, R. E. Nordquist, “Induced anti-tumor immunity against DMBA-4 metastatic mammary tumors in rats using a novel approach,” Int. J. Cancer 107, 1053–1057 (2003).
[16] [16] W. R. Chen, M. Korbelik, K. E. Bartels, H. Liu, J. Sun, R. E. Nordquist, “Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant,” Photochem. Photobiol. 81, 190–195 (2005).
Get Citation
Copy Citation Text
XIAOSONG LI, TOMAS HODE, MARIA C. GUERRA, GABRIELA L. FERREL, JOHN A. LUNN, ORN ADALSTEINSSON, ROBERT E. NORDQUIST, WEI R. CHEN. COMBINED EFFECTS OF SELECTIVE PHOTOTHERMAL THERAPY AND IMMUNOADJUVANT AGAINST STAGE IV BREAST CANCER[J]. Journal of Innovative Optical Health Sciences, 2010, 3(4): 279
Received: --
Accepted: --
Published Online: Jan. 10, 2019
The Author Email: CHEN WEI R. (wchen@uco.edu)